433. How Are Psychedelics and Other Part...

Podcasting started as a niche-nerd pursuit. Now it’s a $9 billion industry. Is that a lot? The strange economics of this thing we do. SOURCES:Jim Bankoff, chairman and C.E.O. of Vox Media.Ben Davis, head of digital at WME.Will Page, former chief economist at Spotify and author of ... Show More

An economist calls America’s beef industry a “miracle.” An antitrust scholar calls it “broken.” Maybe they’re both right? SOURCES:Austin Frerick, agriculture antitrust expert, fellow at Yale University, author of Barons: Money, Power, and the Corruption of America's Food Industry ... Show More

That’s the question at the heart of a battle between Kalshi and state gambling regulators. As prediction markets boom, there are other questions, too — about insider trading, market manipulation, and whether the public has turned against them. (Part two of a two-part series.) SOU ... Show More

When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ... Show More

When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ... Show More

<p dir="ltr">Sam Harris speaks with Dr. Jennifer Mitchell and Dr. Sarah Abedi about recent developments in research on psychedelics. They discuss the history of this research and the war on drugs, recent setbacks in the FDA approval process, MDMA as a treatment for post-traumatic ... Show More

<p>Hallucinogenic drugs are currently illegal, but they were once commonly used in psychological treatment. In this episode, Josh and Chuck discuss the rise and fall of psychedelics in treating mood disorders -- and why they're starting to gain favor again.</p><p> </p> Learn more ... Show More

We’re in the midst of a psychedelic renaissance, where this once demonized class of drugs is now front and center receiving attention among entrepreneurs, investors, clinical trials and even patients. In this special conversation, TED Health’s Dr. Shoshana Ungerleider speaks with ... Show More

Mental health disorders touch rich and poor, young and old, in every country around the world. Hear three experts discuss the evidence for interventions, how to get help to the right people, and which problem, if solved, would help the most. Hosted on Acast. See acast.com/privacy ... Show More

<p>Although psychadelic drugs are largely recreational these days, scientists are looking into potential therapeutic uses -- especially in patients for whom nothing else works. Learn how psilocybin may fight depression in this episode of BrainStuff.</p><p> </p> Learn more about y ... Show More